Pallas' cat [Otocolobus (Felis) manul] experiences a high mortality rate from toxoplasmosis. During the period 2006–2016, the overall mortality rate for this species from all causes during the first year of life was 71.59% in European Association of Zoos and Aquaria institutions, with the most significant infectious cause from systemic toxoplasmosis (20.6%) as confirmed by postmortem examination and histopathology. Clindamycin was used starting in 2014 in two collections that had previously experienced 100% mortality rates by toxoplasmosis in kittens less than one year of age, covering key Toxoplasma gondii exposure periods for kittens (n = 17) as a prophylactic measure. This protocol resulted in a 67.03% (95% confidence interval 41.76–78.61%) reduction in the first year mortality rate over a two-year period to 5.88% in those animals treated.
How to translate text using browser tools
17 March 2020
USE OF CLINDAMYCIN IN PALLAS' CATS [OTOCOLOBUS (FELIS) MANUL] TO REDUCE JUVENILE TOXOPLASMOSIS-ASSOCIATED MORTALITY RATES
Simon J. Girling,
Romain Pizzi,
Adam D. Naylor,
Douglas Richardson,
Una Richardson,
Jane Harley,
Georgina Cole,
Donna Brown,
Mary Fraser,
Emma Tillman,
David Barclay
ACCESS THE FULL ARTICLE
clindamycin
mortality
Otocolobus (Felis) manul
Pallas' cat
toxoplasmosis